Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.beem.2013.06.006
- Scopus: eid_2-s2.0-85047689168
- PMID: 24417941
- WOS: WOS:000330817300002
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Signaling mechanisms underlying the insulin-sensitizing effects of adiponectin
Title | Signaling mechanisms underlying the insulin-sensitizing effects of adiponectin |
---|---|
Authors | |
Keywords | adiponectin APPL1 diabetes insulin obesity |
Issue Date | 2014 |
Publisher | Bailliere Tindall. The Journal's web site is located at http://www.elsevier.com/locate/beem |
Citation | Best Practice & Research: Clinical Endocrinology & Metabolism, 2014, v. 28 n. 1, p. 3-13 How to Cite? |
Abstract | Adiponectin is an insulin-sensitizing adipokine with protective effects against a cluster of obesity-related metabolic and cardiovascular disorders. The adipokine exerts its insulin-sensitizing effects by alleviation of obesity-induced ectopic lipid accumulation, lipotoxicity and chronic inflammation, as well as by direct cross-talk with insulin signaling cascades. Adiponectin and insulin signaling pathways converge at the adaptor protein APPL1. On the one hand, APPL1 interacts with adiponectin receptors and mediates both metabolic and vascular actions of adiponectin through activation of AMP-activated protein kinase and p38 MAP kinase. On the other hand, APPL1 potentiates both the actions and secretion of insulin by fine-tuning the Akt activity in multiple insulin target tissues. In obese animals, reduced APPL1 expression contributes to both insulin resistance and defective insulin secretion. This review summarizes recent advances on the molecular mechanisms by which adiponectin sensitizes insulin actions, and discusses the roles of APPL1 in regulating both adiponectin and insulin signaling cascades. |
Persistent Identifier | http://hdl.handle.net/10722/189276 |
ISSN | 2023 Impact Factor: 6.1 2023 SCImago Journal Rankings: 1.892 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cheng, KY | en_US |
dc.contributor.author | Lam, KSL | en_US |
dc.contributor.author | Wang, B | en_US |
dc.contributor.author | Xu, A | en_US |
dc.date.accessioned | 2013-09-17T14:31:13Z | - |
dc.date.available | 2013-09-17T14:31:13Z | - |
dc.date.issued | 2014 | en_US |
dc.identifier.citation | Best Practice & Research: Clinical Endocrinology & Metabolism, 2014, v. 28 n. 1, p. 3-13 | en_US |
dc.identifier.issn | 1521-690X | - |
dc.identifier.uri | http://hdl.handle.net/10722/189276 | - |
dc.description.abstract | Adiponectin is an insulin-sensitizing adipokine with protective effects against a cluster of obesity-related metabolic and cardiovascular disorders. The adipokine exerts its insulin-sensitizing effects by alleviation of obesity-induced ectopic lipid accumulation, lipotoxicity and chronic inflammation, as well as by direct cross-talk with insulin signaling cascades. Adiponectin and insulin signaling pathways converge at the adaptor protein APPL1. On the one hand, APPL1 interacts with adiponectin receptors and mediates both metabolic and vascular actions of adiponectin through activation of AMP-activated protein kinase and p38 MAP kinase. On the other hand, APPL1 potentiates both the actions and secretion of insulin by fine-tuning the Akt activity in multiple insulin target tissues. In obese animals, reduced APPL1 expression contributes to both insulin resistance and defective insulin secretion. This review summarizes recent advances on the molecular mechanisms by which adiponectin sensitizes insulin actions, and discusses the roles of APPL1 in regulating both adiponectin and insulin signaling cascades. | - |
dc.language | eng | en_US |
dc.publisher | Bailliere Tindall. The Journal's web site is located at http://www.elsevier.com/locate/beem | - |
dc.relation.ispartof | Best Practice & Research: Clinical Endocrinology & Metabolism | en_US |
dc.subject | adiponectin | - |
dc.subject | APPL1 | - |
dc.subject | diabetes | - |
dc.subject | insulin | - |
dc.subject | obesity | - |
dc.title | Signaling mechanisms underlying the insulin-sensitizing effects of adiponectin | en_US |
dc.type | Article | en_US |
dc.identifier.email | Cheng, KY: dorncky@hkucc.hku.hk | en_US |
dc.identifier.email | Lam, KSL: ksllam@hku.hk | en_US |
dc.identifier.email | Xu, A: amxu@hkucc.hku.hk | en_US |
dc.identifier.authority | Cheng, KY=rp01672 | en_US |
dc.identifier.authority | Lam, KSL=rp00343 | en_US |
dc.identifier.authority | Xu, A=rp00485 | en_US |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1016/j.beem.2013.06.006 | - |
dc.identifier.pmid | 24417941 | - |
dc.identifier.scopus | eid_2-s2.0-85047689168 | - |
dc.identifier.hkuros | 225101 | en_US |
dc.identifier.hkuros | 227960 | - |
dc.identifier.volume | 28 | - |
dc.identifier.issue | 1 | - |
dc.identifier.spage | 3 | - |
dc.identifier.epage | 13 | - |
dc.identifier.isi | WOS:000330817300002 | - |
dc.publisher.place | United Kingdom | - |
dc.identifier.issnl | 1521-690X | - |